| 糖尿病并发症的药物治疗 |
| |
| 引用本文： | 赵晶,戴德哉. 糖尿病并发症的药物治疗[J]. 药学进展, 2003, 27(2): 88-91 |
| |
| 作者姓名： | 赵晶 戴德哉 |
| |
| 作者单位： | 中国药科大学药理研究室,江苏,南京,210009 |
| |
| 摘 要： | 糖尿病并发症对人类健康造成极大危害，针对各种糖尿病并发症的病因开发其治疗药物已成为人们关注的热点，并取得可喜进展。本文分类概述糖尿病并发症治疗药物的作用机制、临床应用及疗效研究，其药物包括醛糖还原酶抑制剂、糖基化终产物抑制剂、抗氧剂以及血管紧张素转换酶抑制剂。
|
| 关 键 词： | 糖尿病 并发症 药物治疗 醛糖还原酶抑制剂 糖基化终产物抑制剂 抗氧剂 血管紧张素转换酶抑制剂 |
| 文章编号： | 1001-5094(2003)02-0088-04 |
| 修稿时间： | 2003-02-20 |
Development of Drugs for Treatment of Diabetic Complication |
| |
| ZHAO Jing, DAI De-zai. Development of Drugs for Treatment of Diabetic Complication[J]. Progress in Pharmaceutical Sciences, 2003, 27(2): 88-91 |
| |
| Authors: | ZHAO Jing DAI De-zai |
| |
| Abstract: | Diabetic complication is a disease threatening health. The development of drugs targeting different cause of the disease has been widely concerned. In t his article, the acting mechanisms, clinical applications and efficacies of thes e drugs, which include aldose reductase inhibitors, AGE inhibi tors, antioxidants, ACE inhibitor, etc., were introduced classifiedly. |
| |
| Keywords: | Diabetic complication Aldose reductase inhibitor AGE inhibitor Antioxidant ACE inhibitor |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
